1. Identify outcomes of use of apixaban and potential reduction to risk of bleeding compared with warfarin in ESRD patients.
09/20/2018 - 1:00pm to 2:00pm CDT
UCMC AMB W-507
Chicago, IL 60637
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Dr. Saurabh Chawla